Clinicopathological and molecular epidemiological study of lung cancer patients seen at a tertiary care hospital in Northern India.

about

Clinicopathological and molecular epidemiological study of lung cancer patients seen at a tertiary care hospital in Northern India.

Item

http://www.wikidata.org/entity/Q49544836

description

2017 nî lūn-bûn

@nan

2017 թվականի հոկտեմբերին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

name

Clinicopathological and molecu ...... re hospital in Northern India.

@en

Clinicopathological and molecu ...... re hospital in Northern India.

@nl

type

Item

label

Clinicopathological and molecu ...... re hospital in Northern India.

@en

Clinicopathological and molecu ...... re hospital in Northern India.

@nl

prefLabel

Clinicopathological and molecu ...... re hospital in Northern India.

@en

Clinicopathological and molecu ...... re hospital in Northern India.

@nl

P1476

Clinicopathological and molecu ...... re hospital in Northern India.

@en

P2093

Nitesh Rohtagi

http://www.w3.org/2001/XMLSchema#string

Randeep Singh

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

Cancer statistics, 2008

Cancer statistics, 2013

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study

Lung cancer in India.

Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression

The efficacy and safety of crizotinib in the treatment of anaplastic lymphoma kinase-positive non-small cell lung cancer: a meta-analysis of clinical trials.

P304

171-175

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/SAJC.SAJC_63_17

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29404298

http://www.w3.org/2001/XMLSchema#string

P932

5763630

http://www.w3.org/2001/XMLSchema#string